Brian Stolz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Stolz
Brian Stolz is recorded as COO at BridgeBio Pharma, Inc. (BBIO). The proxy statement of BridgeBio Pharma, Inc. reports total compensation of $5,240,851 for Brian Stolz in fiscal 2020, including a base salary of $511,362. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BridgeBio Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Neil Kumar CEO, Board Member
- Charles Homcy Chairman, Board Member
- Brian Stephenson CFO
- Thomas Trimarchi CFO, COO
- Brian C. Stephenson Chief Accounting Officer
- Ali J. Satvat Board Member
- Andrea Ellis Board Member
- Andrea J. Ellis Board Member
- Andrew W. Lo Board Member
- Douglas A. Dachille Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | BridgeBio Pharma, Inc. (BBIO) | Chief Operating Officer | $511,362 | $5,240,851 |
| 2019 | BridgeBio Pharma, Inc. (BBIO) | Chief Operating Officer | $146,780 | $8,146,313 |
Recent activity
No call appearances or filed executive changes recorded yet.